Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic review.

Lipoprotein(a) carotid atherosclerosis systematic review vulnerable plaque

Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 05 09 2024
revised: 15 09 2024
accepted: 17 09 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 21 9 2024
Statut: aheadofprint

Résumé

The role of lipoprotein(a) [Lp(a)] as a potential risk factor for atherosclerotic arterial disease has been extensively studied. However, the available data regarding its association with the vulnerability of carotid atherosclerotic plaque is limited. The main objective of the present systematic review was to assess the association between elevated Lp(a) levels and carotid vulnerable plaque features. This systematic review adhered to PRISMA guidelines, conducting a comprehensive literature search to identify studies examining the association between Lp(a) levels and vulnerability of carotid atherosclerotic plaque. Experimental or observational studies were eligible, without language, country, or publication type restrictions. Nine studies including 2058 patients were eligible for this systematic review. Five cross-sectional studies, 3 prospective/retrospective cohorts, and 1 subanalysis of a randomized controlled trial were analyzed. Two cross-sectional studies that compared Lp(a) levels between patients with and without vulnerable carotid plaque showed discordant results. Nevertheless, all the studies that evaluated the prevalence or incidence of vulnerable carotid plaque according to Lp(a) levels showed a positive association. Similarly, one study found a significant correlation between vulnerability of carotid plaque and Lp(a) levels. Almost all studies analyzed in the present review showed a positive association between elevated Lp(a) levels and carotid vulnerable plaque features. However, further research is needed to clarify this issue.

Sections du résumé

BACKGROUND BACKGROUND
The role of lipoprotein(a) [Lp(a)] as a potential risk factor for atherosclerotic arterial disease has been extensively studied. However, the available data regarding its association with the vulnerability of carotid atherosclerotic plaque is limited. The main objective of the present systematic review was to assess the association between elevated Lp(a) levels and carotid vulnerable plaque features.
METHODS METHODS
This systematic review adhered to PRISMA guidelines, conducting a comprehensive literature search to identify studies examining the association between Lp(a) levels and vulnerability of carotid atherosclerotic plaque. Experimental or observational studies were eligible, without language, country, or publication type restrictions.
RESULTS RESULTS
Nine studies including 2058 patients were eligible for this systematic review. Five cross-sectional studies, 3 prospective/retrospective cohorts, and 1 subanalysis of a randomized controlled trial were analyzed. Two cross-sectional studies that compared Lp(a) levels between patients with and without vulnerable carotid plaque showed discordant results. Nevertheless, all the studies that evaluated the prevalence or incidence of vulnerable carotid plaque according to Lp(a) levels showed a positive association. Similarly, one study found a significant correlation between vulnerability of carotid plaque and Lp(a) levels.
CONCLUSION CONCLUSIONS
Almost all studies analyzed in the present review showed a positive association between elevated Lp(a) levels and carotid vulnerable plaque features. However, further research is needed to clarify this issue.

Identifiants

pubmed: 39306058
pii: S1052-3057(24)00465-8
doi: 10.1016/j.jstrokecerebrovasdis.2024.108020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108020

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fernando Garagoli (F)

Cardiology Department. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: fernando.garagoli@hospitalitaliano.org.ar.

Walter Masson (W)

Cardiology Department. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: walter.masson@hospitalitaliano.org.ar.

Leandro Barbagelata (L)

Cardiology Department. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: leandro.barbagelata@hospitalitaliano.org.ar.

Classifications MeSH